— Know what they know.
Not Investment Advice
Also trades as: RAD.AX (ASX) · $vol 0M

RADX Earnings

Radiopharm Theranostics Limited
1W: -12.1% 1M: -32.9% 3M: -66.7% YTD: -71.9% 1Y: -74.7%
$1.42
-0.06 (-4.05%)
 
Weekly Expected Move ±15.7%
$1 $1 $1 $2 $2
NASDAQ · Healthcare · Biotechnology · Tech Score Sell · Power 40 · $1.8M mcap · 819522 float · 7.90% daily turnover · Short 60% of daily vol
Last Earnings 2026-08-28
EPS
A$-1.20 (US$-0.83)
▲ Beat +28.4%
Revenue
A$699K ($486K)
▼ Miss -17.3%

Estimate vs Actual

Earnings Surprise History

1/2
EPS Beats
1/2
Revenue Beats
50%
EPS Beat Rate
50%
Rev Beat Rate

Wall Street Forward Estimates

Quarterly
Annual

Estimate Revisions

Recent Revisions
DatePeriodFiscal DateEPS OldEPS NewChangeRev OldRev New
2026-09-14 annual 2027-06-30 A$-4.17 A$-3.15 ▲ 1.02 A$2,561,713 A$2,192,013
2026-09-14 annual 2028-06-30 A$-5.86 A$-3.04 ▲ 2.82 A$3,647,871 A$2,676,543
2026-08-20 annual 2026-06-30 A$-3.86 A$-3.66 ▲ 0.20 A$2,411,949 A$2,386,833
2026-08-20 annual 2028-06-30 A$-5.91 A$-5.86 ▲ 0.05 A$3,692,077 A$3,647,871
2026-08-20 annual 2027-06-30 A$-4.73 A$-4.17 ▲ 0.56 A$2,587,756 A$2,561,713
2026-07-30 annual 2027-06-30 A$-6.20 A$-4.73 ▲ 1.47 A$2,872,267 A$2,587,756
2026-07-30 annual 2026-06-30 A$-3.79 A$-3.86 ▼ 0.07 A$2,608,557 A$2,411,949
2026-07-17 annual 2030-06-30 A$2.29 A$2.30 ▲ 0.01 A$163,769,202 A$163,928,190
2026-07-17 annual 2029-06-30 A$-0.62 A$-0.62 — A$83,550,947 A$83,632,059
2026-07-17 annual 2028-06-30 A$-5.90 A$-5.91 ▼ 0.01 A$3,688,496 A$3,692,077
2026-07-17 annual 2027-06-30 A$-6.19 A$-6.20 ▼ 0.01 A$2,869,481 A$2,872,267
2026-07-17 annual 2026-06-30 A$-3.78 A$-3.79 ▼ 0.01 A$2,606,027 A$2,608,557
2026-07-16 annual 2029-06-30 A$-0.62 A$-0.62 — A$83,601,159 A$83,550,947
2026-07-16 annual 2028-06-30 A$-5.91 A$-5.90 ▲ 0.01 A$3,690,713 A$3,688,496
2026-07-16 annual 2030-06-30 A$2.29 A$2.29 — A$163,867,623 A$163,769,202
Earnings Call Transcripts
No transcripts available.

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms